| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | Aug 4, 2023 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 36.3 | -509 | -0.96% | ✗ | $17.8K |
| Jun 6, 2023 | Jun 7, 2023 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 22.5 | -3,636 | -8.08% | ✗ | $139.7K |
| Aug 3, 2022 | Aug 5, 2022 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 26.3 | -476 | -1.05% | ✗ | $26.5K |
| Jun 6, 2022 | Jun 8, 2022 | Pacira BioSciences, Inc. | Chief Medical Officer | Sell | 40.0 | -7,646 | -1.79% | ✓ | $1.1M |
| Jun 4, 2021 | Jun 8, 2021 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 22.5 | -2,276 | -8.65% | ✗ | $138.9K |
| Mar 31, 2021 | Apr 2, 2021 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 5.0 | -22,224 | -45.79% | ✓ | $1.6M |
| Nov 13, 2020 | Nov 17, 2020 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 22.5 | -5,000 | -12.57% | ✓ | $310K |
| Mar 11, 2020 | Mar 12, 2020 | Pacira BioSciences, Inc. | Chief Clinical Officer | Buy | 95.0 | +2,500 | 11.00% | ✗ | $91.3K |
| Jun 4, 2019 | Jun 6, 2019 | Pacira BioSciences, Inc. | Chief Clinical Officer | Sell | 91.3 | +4,878 | 28.26% | ✗ | $31K |